Ohio Public Employees Retirement System (OPERS)’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Other funds holding DSGN
SOCM
RCM
BBA
LGM
DCM
VC
AC
VCM
Ohio Public Employees Retirement System (OPERS)'s DSGN Position: Q1 2026 in Review
Ohio Public Employees Retirement System (OPERS) increased its Design Therapeutics (DSGN) stake by 114% in Q1 2026, buying an estimated $82K and bringing the position to 15,193 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #1710.
Ohio Public Employees Retirement System (OPERS) first reported a position in DSGN in Q4 2023 and has held it in 6 quarters since. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.
- Ohio Public Employees Retirement System (OPERS) held 15,193 shares of Design Therapeutics worth $162K as of Q1 2026.
- Ohio Public Employees Retirement System (OPERS) bought 8,100 Design Therapeutics shares in Q1 2026, an estimated $82K.
- Design Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q1 2026, its #1710 holding.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Design Therapeutics in Q4 2023 and has held it in 6 quarters since.
- 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.